Goin Kathleen

Chief Operating OfficerPALVELLA THERAPEUTICS, INC. (PVLA) · full profile →Form 4 · filed Apr 17, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$547K
Net Open-Market Flow
-$547K
Transactions
9
7 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 15, 2026Option exercise(M)2K$7.14$15K2K
Apr 15, 2026Option exercise(M)2K$9.08$20K4K
Apr 15, 2026Sell(S)2K$125.96$189K3K
Apr 15, 2026Sell(S)2K$127.13$191K1K
Apr 15, 2026Sell(S)561$128.23$72K739
Apr 15, 2026Sell(S)639$129.17$83K100
Apr 15, 2026Sell(S)100$130.33$13K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 15, 2026Option exercise(M)2K$013K
Apr 15, 2026Option exercise(M)2K$013K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-044895) within minutes of acceptance. Every field above traces to the original document. Verify it directly: